| OPEFELI Glaxo Group Limited
97558862 22 Aug 2022 | on 26 Sep 2023
| Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | OPEFELI Glaxo Group Limited
86942419 16 Mar 2016 | on 28 Apr 2023 | Vaccines; Pharmaceutical preparations and substances for the treatment... Class 005 Class 005 Pharmaceutical Products Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders | | 
